Bank Of New York Mellon Corp Oncocyte Corp Transaction History

Bank Of New York Mellon Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.25 - $15.6 $15,776 - $984,469	63,107 New	63,107 $20,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $128,852 - $229,236	-149,828 Reduced 70.31%	63,270 $57,000
Q1 2022 May 11, 2022	SELL	$1.15 - $2.25 $1,723 - $3,372	-1,499 Reduced 0.7%	213,098 $317,000
Q4 2021 Feb 11, 2022	BUY	$2.04 - $3.59 $6,797 - $11,961	3,332 Added 1.58%	214,597 $466,000
Q3 2021 Nov 12, 2021	BUY	$3.53 - $5.89 $55,029 - $91,819	15,589 Added 7.97%	211,265 $752,000
Q2 2021 Aug 11, 2021	BUY	$3.77 - $6.0 $45,903 - $73,056	12,176 Added 6.64%	195,676 $1.12 Million
Q1 2021 May 13, 2021	BUY	$2.39 - $6.5 $38,522 - $104,767	16,118 Added 9.63%	183,500 $952,000
Q4 2020 Feb 09, 2021	BUY	$1.38 - $2.63 $68,844 - $131,202	49,887 Added 42.46%	167,382 $400,000
Q2 2020 Aug 12, 2020	BUY	$1.91 - $3.45 $94,835 - $171,299	49,652 Added 73.19%	117,495 $224,000
Q1 2020 May 06, 2020	BUY	$1.76 - $3.02 $23,768 - $40,785	13,505 Added 24.85%	67,843 $166,000
Q3 2019 Nov 07, 2019	SELL	$1.59 - $2.51 $37,175 - $58,686	-23,381 Reduced 30.08%	54,338 $114,000
Q2 2019 Aug 12, 2019	BUY	$2.49 - $5.45 $145,032 - $317,440	58,246 Added 299.11%	77,719 $194,000
Q1 2019 May 14, 2019	BUY	$1.47 - $5.91 $28,625 - $115,085	19,473 New	19,473 $77,000
Q1 2018 May 15, 2018	SELL	$1.25 - $4.6 $20,978 - $77,201	-16,783 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.4 $65,453 - $124,194	16,783	16,783 $78,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $260M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.